Comments
Sanofi eyes 2015 launch of novel cholesterol drug
20.07.2012. | (Reuters) - French drugmaker Sanofi said it and partner Regeneron Pharmaceuticals Inc have begun enrolling more than 20,000 patients for 10 late-stage trials of their novel cholesterol fighter REGN727, and are hoping the medicine will be approved by late 2015....
